BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5067490)

  • 1. [The indicative value of central hemodynamic changes following the administration of an o-nitrophenyl-dihydropyridine derivative].
    Schneider KW; Jesse R
    Arzneimittelforschung; 1972 Feb; 22(2):373-7. PubMed ID: 5067490
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiohemodynamic effects of BAY a 1040 in the dog.
    Hashimoto K; Taira N; Chiba S; Hashimoto K; Endo M
    Arzneimittelforschung; 1972 Jan; 22(1):15-21. PubMed ID: 5066992
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
    Hayase S; Hirakawa S; Hosokawa S; Mori N; Kanyama S
    Arzneimittelforschung; 1972 Feb; 22(2):370-3. PubMed ID: 4554632
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid methyl ester on myocardial metabolism, hemodynamics, blood gases and general metabolism of man].
    Kochsiek K; Neubaur J
    Arzneimittelforschung; 1972 Feb; 22(2):353-8. PubMed ID: 5067487
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
    Vater W; Kroneberg G; Hoffmeister F; Saller H; Meng K; Oberdorf A; Puls W; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic effects of Bay a 1040 before and after atropine administration].
    Lydtin H; Lohmöller R
    Verh Dtsch Ges Inn Med; 1972; 78():1554-9. PubMed ID: 4665607
    [No Abstract]   [Full Text] [Related]  

  • 8. The incidence and relative frequencies of congenital heart disease in school children aged 7 to 16 in Shiga Prefecture.
    Hayase S; Hirakawa S; Hosokawa S; Mori N; Ito H
    Jpn Circ J; 1971 Aug; 35(8):903-14. PubMed ID: 5171691
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive effect of (4-2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (Nifedipine, Bay-a 1040), a new coronary dilator.
    Murakami M; Murakami E; Takekoshi N; Tsuchiya M; Kin T
    Jpn Heart J; 1972 Mar; 13(2):128-35. PubMed ID: 4537344
    [No Abstract]   [Full Text] [Related]  

  • 10. [Informative value of changes in central hemodynamics for the clinical use of various coronary-effective drugs].
    Schneider KW; Jesse R
    Verh Dtsch Ges Inn Med; 1971; 77():976-9. PubMed ID: 5005553
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of BAY a 1040 on oxygen supply of the isolated perfused and arrested guinea pig heart].
    Follert EK
    Arzneimittelforschung; 1972 Feb; 22(2):349-53. PubMed ID: 5067486
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nitroglycerin and 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester tested on rabbit heart under hypoxic respiration].
    Thorn W
    Arzneimittelforschung; 1972 Jan; 22(1):56-60. PubMed ID: 4622473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changed hemodynamics of the left heart under the influence of Nifedipine (BAY a 1040) as compared to nitroglycerin].
    Kaltenbach M; Becker HJ; Kober G; Loos A
    Arzneimittelforschung; 1972 Feb; 22(2):362-5. PubMed ID: 4623699
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute action of nifedipine on the heart and circulation of dogs before and after oral long-term treatment].
    van Ackern K; Braasch W; Brückner UB; Hakimi B; Schmier J; Simo I
    Arzneimittelforschung; 1974 Oct; 24(10):1574-7. PubMed ID: 4479764
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic effect of Nifedipine (BAY a 1040) before and following cardiac sympathetic blockade by practolol (ICI 50 172)].
    Lohmöller R; Lydtin H
    Int J Clin Pharmacol; 1973 Oct; 8(2):118-25. PubMed ID: 4148668
    [No Abstract]   [Full Text] [Related]  

  • 16. [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
    Fleckenstein A; Tritthart H; Döring HJ; Byon KY
    Arzneimittelforschung; 1972 Jan; 22(1):22-33. PubMed ID: 4259147
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of the nitrophenyl-dimethyl-dihydropyridine derivative nifedipine on intercoronary collateral circulation.
    Kanazawa T; Suzuki N; Ino-oka E; Takahashi T; Mori A
    Arzneimittelforschung; 1974 Sep; 24(9):1267-74. PubMed ID: 4479789
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine.
    Cherchi A; Fonzo R; Bina M
    G Ital Cardiol; 1974; 4(5):565-74. PubMed ID: 4215687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.